Literature DB >> 12512810

Biological studies on the snail intermediate hosts of schistosomiasis with a special emphasis on using larval echinostomes as biocontrol agent against larval schistosomes and snails.

A A Rashed1.   

Abstract

The present investigation deals with the infectivity of the two snail intermediate hosts of schistosomiasis, Biomphalaria alexandrina and Bulinus truncatus collected from nine drains in Sharkia Governorate, Egypt. The rate of infection among the snails was general low being 0% in many drains. Regarding B. alexandrina, the rate of infection ranged from 4-16%, and in B. truncatus ranged from 4-8%. Infection with larval echinostomes was dominant over larval schistosomes in the two snail vectors. The distribution of larval schistosomes was restricted to the hepatopancreas of the two snail vectors, while larval echinostomes were distributed in head, foot, kidney, haemocoelic cavity, hepatopancreas...etc. The predation of larval schistosomes by larval echinostomes and the severe histopathological effects induced by larval ecbinostomes strongly enhances using them as biocontrol agent. The physico-chemical parameters and pollution condition in the drains seem to have no effect on the process of snails infectivity. It is concluded that larval echinostomes can resist the polluting conditions in the drain. The two snail vectors exhibit very minimal or rare host response against larval echinostomes. Probably, the toxicants and pollutants in the drain may act as stressor that makes the snails much more susceptible to infection by larval trematodes.

Entities:  

Mesh:

Year:  2002        PMID: 12512810

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  1 in total

1.  The diverse echinostomes from East Africa: With a focus on species that use Biomphalaria and Bulinus as intermediate hosts.

Authors:  Martina R Laidemitt; Sara V Brant; Martin W Mutuku; Gerald M Mkoji; Eric S Loker
Journal:  Acta Trop       Date:  2019-01-30       Impact factor: 3.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.